Main > PNEUMOLOGY > Bronchitis > Treatment > Co.: KR. L. GemiFloxacin Mesylate

---

Co.: KR. L. GemiFloxacin Mesylate's subsections
Company
FluoroQuinolone
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 17
Patent>UpDate: 2009. 04.28.
Patent>USA Expiration: 2018
TradeMark
USA Launch Date: 2004. 09.

Co.: KR. L. GemiFloxacin Mesylate's products
This section has no products